Bain Capital Life Sciences Investors’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,364,410	Closed	-$25.8M	–	36
2022 Q4	$25.8M	Buy	2,364,410 +103,838	+5%	+$1.13M	2.88%	11
2022 Q3	$19.1M	Hold	2,260,572	–	–	2.27%	16
2022 Q2	$17.9M	Buy	+2,260,572	New	+$17.9M	2.1%	14